 |
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Invasive rare mold infections caused by scedosporium spp., fusarium spp., and mucorales fungi (including mucor spp., and rhizopus spp.) |
| USA Market Approval | USA |
| USA Designation Date | 2016-11-02 00:00:00 |
| Sponsor | Amplyx Pharmaceuticals, Inc.;12730 High Bluff Drive, Suite 160;San Diego, California, 92130 |
